| |
| |
|
| Insider
Information: |
Payne Fletcher |
| Relationship: |
SR VP & Chief Fin. Off... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
103,744 |
|
|
Indirect Shares
|
11,167 |
|
|
| Direct
Value |
$124,914 |
|
|
|
Indirect Value
|
$12,897 |
|
|
| Total
Shares |
114,911 |
|
|
| Total
Value |
$137,811 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -19.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
Chief Financial Officer |
2019-08-12 |
3,744 |
2019-08-12 |
1,167 |
Premium* |
|
|
Aptose Biosciences Inc |
APTO |
SR VP & Chief Fin. Off... |
2023-01-19 |
100,000 |
2023-01-19 |
10,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APTO |
Aptose Biosciences Inc |
SR VP & Chief Fin. Officer |
• – – |
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
0 |
- |
|
| APTO |
Aptose Biosciences Inc |
SR VP & Chief Fin. Officer |
• – – |
2022-09-19 |
4 |
B |
$0.68 |
$6,775 |
I/I |
10,000 |
10,000 |
1.99 |
% |
|
| GYRE |
Gyre Therapeutics |
Chief Financial Officer |
• – – |
2019-08-12 |
4 |
A |
$6.51 |
$7,682 |
D/D |
1,180 |
3,744 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Financial Officer |
• – – |
2019-02-11 |
4 |
A |
$7.04 |
$7,054 |
D/D |
1,002 |
3,731 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Financial Officer |
• – – |
2019-02-04 |
4 |
OE |
$4.63 |
$6,959 |
D/D |
1,503 |
3,230 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Financial Officer |
• – – |
2018-03-26 |
4 |
OE |
$4.63 |
$273 |
D/D |
59 |
59 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Financial Officer |
• – – |
2015-12-17 |
4 |
B |
$2.00 |
$20,000 |
I/I |
10,000 |
25,032 |
1.99 |
- |
|
| GYRE |
Gyre Therapeutics |
Chief Financial Officer |
• – – |
2015-08-20 |
4 |
A |
$0.00 |
$0 |
I/I |
15,032 |
15,032 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
